DrugRisk Update: Takeda Launches New Diabetes Drug As Actos Lawsuits Grow to 3,000

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
actos lawsuit
Anyone diagnosed with bladder cancer after taking Actos is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Dallas, TX (PRWEB) February 27, 2013

The prescription drug resource center DrugRisk.com is alerting diabetes patients of updated news added to the site – drug maker Takeda Pharmaceuticals, who makes Actos, is set to launch a new diabetes medication as they face as many as 3,000 lawsuits alleging Actos caused bladder cancer.

“DrugRisk’s goal is to improve patient safety through education. By providing the latest drug warnings, recalls, studies and litigation news, patients can discuss options with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center contains Actos warnings from both the FDA* and European Medicines Agency** who indicated that long-term use of the drug may be associated with an increased risk of Actos bladder cancer. The drug has also been banned in France and Germany.***

In legal news, DrugRisk has learned that Takeda faces as many as 3,000 claims over Actos bladder cancer.**** More than 1,200 patients have filed an Actos lawsuit against the drug maker in a special multi-district federal court in Louisiana.***** Another group of cases were scheduled to start last week in California.****

Now, with the growing legal action and the patent on Actos expiring last year, Takeda has received FDA approval to launch the new diabetes medication Nesina.**** Patients are urged to speak with their doctor about the safest options to treat diabetes.

Lawyers are still helping those affected by Actos file claims. Anyone diagnosed with bladder cancer after taking Actos is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

For more information on the research, side effects and litigation news related to Actos and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos
**ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/human_pha_detail_000033.jsp&mid=WC0b01ac058001d126
***cbsnews.com/8301-504763_162-20070492-10391704.html
****bloomberg.com/news/2013-02-19/takeda-faces-first-trial-over-actos-diabetes-drug-in-l-a-.html
***** In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).


Contact